Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2003

01-09-2003 | Brief Report

Influence of Microbiological Reports on Physician's Choice of Antimicrobial Treatment for Susceptible Pathogens

Authors: J. Cobo, J. Oliva, J. Sanz, J. M. Aguado, J. del Pozo, S. Moreno

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2003

Login to get access

Excerpt

The empirical use of broad-spectrum antibiotics provides good coverage for most pathogens during the first days of therapy for presumed bacterial infections. Once culture results and susceptibility tests are available, however, clinicians have the opportunity to narrow the spectrum and simplify antimicrobial therapy. Nevertheless, some authors have reported that this information is frequently overlooked and/or misinterpreted by physicians [1, 2, 3]. …
Literature
1.
Arbo MD, Snydman DR (1994) Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 154:2641–2645PubMed
2.
Campo L (1988) Use of microbiology reports by physicians in prescribing antimicrobial agents. Am J Med Sci 296:392–398PubMed
3.
Elhanan G, Sarhat M, Raz R (1997) Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community acquired bacteremia due to urinary tract infection. J Infect 35:283–288
4.
Chow JW, Fine MJ, Schales DM et al. (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115:585–590PubMed
5.
Moellering RC Jr (1995) Principles of anti-infective therapy. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 4th edn. Churchill Livingstone, Philadelphia, pp 199–212
6.
Gilbert DN, Moellering RC Jr, Sande ME (1998) Sandford guide to antimicrobial therapy, 28th edn. Antimicrobial Guide, Hyde Park, VT, pp 48–50
7.
Yu VL, Stoehr GP, Starling RC, Shogan JE (1991) Empiric antibiotic selection by physicians: evaluation of reasoning strategies. Am J Med Sci 301:165–172PubMed
8.
Trenholme GM, Kaplan RL, Karakusis PH, Stine T, Fuhrer J, Landau W et al. (1989) Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol 27:1342–1345PubMed
9.
Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A et al. (1999) Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29:60–66PubMed
10.
Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF et al. (1998) A computer-assisted management program for antibiotics and other antiinfective agents. New Engl J Med 338:232–238CrossRefPubMed
Metadata
Title
Influence of Microbiological Reports on Physician's Choice of Antimicrobial Treatment for Susceptible Pathogens
Authors
J. Cobo
J. Oliva
J. Sanz
J. M. Aguado
J. del Pozo
S. Moreno
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-0978-3

Other articles of this Issue 9/2003

European Journal of Clinical Microbiology & Infectious Diseases 9/2003 Go to the issue

Brief Report

Helicobacter pylori Genotypes in Russia

Article

High Frequency of Antibiotic-Associated Diarrhea due to Toxin A-Negative, Toxin B-Positive Clostridium difficile in a Hospital in Japan and Risk Factors for Infection

Announcements

September 2003

Concise Article

Plasmodium falciparum Cerebral Malaria Complicated by Disseminated Intravascular Coagulation and Symmetrical Peripheral Gangrene: Case Report and Review

Brief Report

Successful Treatment of an Aspergillus Brain Abscess with Caspofungin: Case Report of a Diabetic Patient Intolerant of Amphotericin B

Concise Article

Comparative In Vitro Activity of Faropenem and 11 Other Antimicrobial Agents Against 250 Invasive Streptococcus pneumoniae Isolates from France
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits